Regulus Therapeutics (RGLS) Short Interest Ratio & Short Volume $1.47 +0.07 (+5.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Regulus Therapeutics Short Interest DataRegulus Therapeutics (RGLS) has a short interest of 1.69 million shares, representing 3.19% of the float (the number of shares available for trading by the public). This marks a -32.40% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 500,064 shares to cover all short positions.Current Short Interest1,690,000 sharesPrevious Short Interest2,500,000 sharesChange Vs. Previous Month-32.40%Dollar Volume Sold Short$2.47 millionShort Interest Ratio4.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares65,500,000 sharesFloat Size52,920,000 sharesShort Percent of Float3.19%Today's Trading Volume288,016 sharesAverage Trading Volume500,064 sharesToday's Volume Vs. Average58% Short Selling Regulus Therapeutics? Sign up to receive the latest short interest report for Regulus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRGLS Short Interest Over TimeRGLS Days to Cover Over TimeRGLS Percentage of Float Shorted Over Time Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Regulus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,690,000 shares $2.47 million -32.4%3.2%4.7 $1.46 10/15/20242,500,000 shares $3.75 million -12.3%4.7%7.3 $1.50 9/30/20242,850,000 shares $4.47 million -13.4%5.4%7.7 $1.57 9/15/20243,290,000 shares $5.30 million -1.2%6.2%4.6 $1.61 8/31/20243,330,000 shares $5.59 million -7.0%6.3%4.2 $1.68 8/15/20243,580,000 shares $5.69 million -8.7%6.8%4.4 $1.59 Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20243,920,000 shares $7.06 million -9.7%7.4%4.6 $1.80 7/15/20244,340,000 shares $7.55 million -18.1%8.2%5.3 $1.74 6/30/20245,300,000 shares $9.46 million +48.0%10.0%6.6 $1.79 6/15/20243,580,000 shares $8.63 million +38.2%6.8%5.1 $2.41 5/31/20242,590,000 shares $5.93 million -10.1%4.9%0.8 $2.29 5/15/20242,880,000 shares $5.82 million -31.6%5.4%0.9 $2.02 4/30/20244,210,000 shares $9.68 million -32.9%7.3%1.4 $2.30 4/15/20246,270,000 shares $17.43 million +15.7%10.9%2.1 $2.78 3/31/20245,420,000 shares $15.61 million +5.7%9.4%1.8 $2.88 3/15/20245,130,000 shares $10.82 million +9,244.3%13.0%1.8 $2.11 2/29/202454,900 shares $80,703.00 -43.4%0.3%1.4 $1.47 2/15/202497,000 shares $143,560.00 -16.6%0.6%2.6 $1.48 1/31/2024116,300 shares $147,701.00 -7.3%0.7%4.4 $1.27 1/15/2024125,500 shares $163,150.00 -9.3%0.7%5.1 $1.30 12/31/2023138,400 shares $177,152.00 -6.6%0.8%6.9 $1.28 12/15/2023148,100 shares $202,897.00 -0.1%0.9%7.6 $1.37 11/30/2023148,200 shares $194,142.00 -18.3%0.9%4.4 $1.31 11/15/2023181,300 shares $252,007.00 -5.2%1.0%4.9 $1.39 10/31/2023191,200 shares $231,352.00 -0.7%1.1%5.4 $1.21 10/15/2023192,600 shares $242,676.00 -1.0%1.2%5.5 $1.26 9/30/2023194,500 shares $266,465.00 -0.2%1.2%5.6 $1.37 9/15/2023194,800 shares $331,160.00 +4.2%1.2%5.6 $1.70 8/31/2023187,000 shares $291,720.00 -10.2%1.1%5.7 $1.56 8/15/2023208,300 shares $281,205.00 -3.7%1.3%9.6 $1.35 7/31/2023216,300 shares $302,820.00 -3.9%1.3%7.8 $1.40 7/15/2023225,000 shares $328,500.00 -2.5%1.4%7.7 $1.46 6/30/2023230,700 shares $339,129.00 +6.5%1.4%4.1 $1.47 6/15/2023216,700 shares $312,048.00 +3.0%1.3%3.4 $1.44 5/31/2023210,300 shares $273,390.00 -17.1%1.3%3.1 $1.30 5/15/2023253,700 shares $393,235.00 +26.0%1.6%3.8 $1.55 4/30/2023201,300 shares $268,735.50 +18.1%1.4%3.4 $1.34 4/15/2023170,500 shares $202,895.00 -13.9%1.2%2.6 $1.19 3/31/2023198,000 shares $167,805.00 +11.1%1.3%4.8 $0.85 3/15/2023178,200 shares $215,622.00 -3.7%1.2%4 $1.21Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now 2/28/2023185,100 shares $248,034.00 -1.9%1.3%4.1 $1.34 2/15/2023188,600 shares $262,154.00 -6.8%1.3%4.2 $1.39 1/31/2023202,400 shares $291,456.00 -3.2%1.4%4.3 $1.44 1/15/2023209,000 shares $311,410.00 +0.8%1.4%4.7 $1.49 12/30/2022207,400 shares $284,138.00 -10.8%1.4%4.7 $1.37 12/15/2022232,600 shares $327,966.00 -16.2%1.6%5.4 $1.41 11/30/2022277,500 shares $474,525.00 -2.6%1.9%0.3 $1.71 11/15/2022284,900 shares $490,028.00 +5.1%2.0%0.3 $1.72 10/31/2022271,100 shares $420,205.00 -1.7%N/A0.3 $1.55 10/15/2022275,900 shares $449,717.00 -7.4%N/A0.3 $1.63 9/30/2022297,900 shares $506,430.00 -49.9%N/A0.3 $1.70 9/15/2022594,600 shares $1.24 million +98.7%N/A0.7 $2.09 8/31/2022299,300 shares $425,006.00 -15.2%N/A0.4 $1.42 8/15/2022353,000 shares $638,930.00 +56.1%N/A3 $1.81 7/31/2022226,200 shares $364,182.00 -7.1%N/A1 $1.61 7/15/2022243,500 shares $560,050.00 +1.4%N/A1.2 $2.30 6/30/2022240,100 shares $497,007.00 -91.3%N/A1.2 $2.07 6/15/20222,770,000 shares $678,927.00 -9.2%N/A1.4 $0.25 5/31/20223,050,000 shares $873,825.00 -30.8%N/A1.5 $0.29 5/15/20224,410,000 shares $948,150.00 +53.1%N/A2 $0.22 4/30/20222,880,000 shares $581,760.00 -10.8%N/A2.7 $0.20 4/15/20223,230,000 shares $823,650.00 -2.4%N/A2.8 $0.26 3/31/20223,310,000 shares $986,380.00 +1.5%N/A2.3 $0.30 3/15/20223,260,000 shares $867,160.00 +21.2%N/A2.3 $0.27 2/28/20222,690,000 shares $605,250.00 -17.5%N/A1.9 $0.23 2/15/20223,260,000 shares $815,326.00 +4.5%N/A2.5 $0.25 1/31/20223,120,000 shares $769,704.00 +24.8%4.2%2.2 $0.25 1/15/20222,500,000 shares $617,500.00 -8.8%3.3%1.5 $0.25 12/31/20212,740,000 shares $863,100.00 -18.7%4.1%1.3 $0.32 12/15/20213,370,000 shares $1.18 million -0.6%5.1%1.6 $0.35 11/30/20213,390,000 shares $1.31 million -19.7%4.5%1.7 $0.39 11/15/20214,220,000 shares $1.76 million -4.5%N/A2.1 $0.42 10/29/20214,420,000 shares $2.04 million -8.3%N/A2.3 $0.46 10/15/20214,820,000 shares $2.34 million -8.5%N/A2.9 $0.49 9/30/20215,270,000 shares $3.64 million +6.0%N/A6.5 $0.69 9/15/20214,970,000 shares $3.48 million +0.4%N/A4 $0.70 8/31/20214,950,000 shares $3.84 million -5.9%N/A1.7 $0.78 8/13/20215,260,000 shares $3.53 million -0.8%N/A1.7 $0.67 7/30/20215,300,000 shares $3.71 million -12.3%8.2%1.7 $0.70 7/15/20216,040,000 shares $4.35 million -2.6%9.3%1.9 $0.72 6/30/20216,200,000 shares $5.04 million +4.7%9.6%1.9 $0.81 6/15/20215,920,000 shares $5.52 million +0.2%9.1%2 $0.93 5/28/20215,910,000 shares $5.83 million No Change9.1%1.6 $0.99 5/14/20215,910,000 shares $4.85 million -5.4%N/A2.1 $0.82 4/30/20216,250,000 shares $9.19 million -3.0%N/A2.1 $1.47 4/15/20216,440,000 shares $8.76 million -3.5%N/A2 $1.36 3/31/20216,670,000 shares $10.41 million +31.3%N/A2.1 $1.56 3/15/20215,080,000 shares $9.96 million +61.8%N/A1.5 $1.96 2/26/20213,140,000 shares $4.11 million +13.8%N/A1.2 $1.31 2/12/20212,760,000 shares $4.50 million +16.0%N/A1.1 $1.63Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now 1/29/20212,380,000 shares $3.33 million +31.5%N/A1.1 $1.40 1/15/20211,810,000 shares $2.15 million +24.0%N/A0.9 $1.19 12/31/20201,460,000 shares $1.88 million +35.2%N/A0.9 $1.29 12/15/20201,080,000 shares $1.24 million +54.8%N/A0.7 $1.15 11/30/2020697,800 shares $444,289.26 -30.0%N/A0.9 $0.64 11/15/2020997,100 shares $518,492.00 +7.0%N/A2.1 $0.52 10/30/2020932,300 shares $444,520.64 +12.9%N/A1.8 $0.48 10/15/2020826,100 shares $450,637.55 -6.8%N/A0.6 $0.55 9/30/2020885,900 shares $455,352.60 -19.5%N/A0.5 $0.51 9/15/20201,100,000 shares $611,600.00 -4.4%N/A0.5 $0.56 8/31/20201,150,000 shares $609,500.00 -27.7%N/A0.4 $0.53 8/14/20201,590,000 shares $969,900.00 -3.6%N/A0.6 $0.61 7/31/20201,650,000 shares $1.16 million +131.2%N/A0.6 $0.70 7/15/2020713,800 shares $548,269.78 +189.8%N/A0.4 $0.77 6/30/2020246,300 shares $176,104.50 -65.8%N/A0.2 $0.72 6/15/2020720,200 shares $677,060.02 +25.6%N/A0.6 $0.94 5/29/2020573,600 shares $430,200.00 -15.9%N/A1 $0.75 5/15/2020681,900 shares $408,458.10 +17.9%N/A2.1 $0.60 4/30/2020578,500 shares $296,770.50 +3.9%N/A2.1 $0.51 4/15/2020556,600 shares $263,438.78 +2.8%3.5%2.7 $0.47 3/31/2020541,500 shares $254,505.00 -2.7%3.4%3 $0.47 3/13/2020556,700 shares $250,515.00 -0.3%3.5%4.7 $0.45 2/28/2020558,200 shares $245,608.00 -1.1%3.5%1.9 $0.44 2/14/2020564,100 shares $383,588.00 -16.5%3.5%1.9 $0.68 1/31/2020675,300 shares $492,969.00 +3.1%4.2%2.4 $0.73 1/15/2020654,800 shares $628,608.00 +35.8%3.8%2.4 $0.96 12/31/2019482,200 shares $564,174.00 +59.1%2.8%1.9 $1.17 RGLS Short Interest - Frequently Asked Questions What is Regulus Therapeutics' current short interest? Short interest is the volume of Regulus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,690,000 shares of RGLS short. 3.19% of Regulus Therapeutics' shares are currently sold short. Learn More on Regulus Therapeutics' current short interest. What is a good short interest ratio for Regulus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGLS shares currently have a short interest ratio of 5.0. Learn More on Regulus Therapeutics's short interest ratio. What is a good short interest percentage for Regulus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.19% of Regulus Therapeutics' floating shares are currently sold short. Is Regulus Therapeutics' short interest increasing or decreasing? Regulus Therapeutics saw a drop in short interest in October. As of October 31st, there was short interest totaling 1,690,000 shares, a drop of 32.4% from the previous total of 2,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Regulus Therapeutics' float size? Regulus Therapeutics currently has issued a total of 65,500,000 shares. Some of Regulus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regulus Therapeutics currently has a public float of 52,920,000 shares. How does Regulus Therapeutics' short interest compare to its competitors? 3.19% of Regulus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Regulus Therapeutics: Alimera Sciences, Inc. (1.10%), XOMA Co. (1.47%), Codexis, Inc. (2.40%), Vanda Pharmaceuticals Inc. (6.77%), Lexicon Pharmaceuticals, Inc. (11.63%), Verastem, Inc. (6.06%), Achieve Life Sciences, Inc. (9.65%), Agenus Inc. (13.16%), Fortress Biotech, Inc. (11.97%), SAB Biotherapeutics, Inc. (0.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Regulus Therapeutics stock? Short selling RGLS is an investing strategy that aims to generate trading profit from Regulus Therapeutics as its price is falling. RGLS shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Regulus Therapeutics? A short squeeze for Regulus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RGLS, which in turn drives the price of the stock up even further. How often is Regulus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGLS, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Alimera Sciences Short Interest XOMA Short Interest Codexis Short Interest Vanda Pharmaceuticals Short Interest Lexicon Pharmaceuticals Short Interest Verastem Short Interest Achieve Life Sciences Short Interest Agenus Short Interest Fortress Biotech Short Interest SAB Biotherapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGLS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regulus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
